ERNST & YOUNG SRL

  |  2014-01-15

Big pharma’s challenges in a competitive M&A environment

A year ago, consensus was that 2013 would be a busy year for acquisitions by big pharma companies as they sought to fi ll their “growth gaps” — the additional revenue they need in order to keep pace with the overall drug market

But things didn’t turn out that way. Big pharma companies executed only a handful of small bolt-on deals, and their share of M&A transactions fell to a new low.

 

For more information, please read the Romanian version of the article, here, or see the attached EY study.

COMMENT ON THIS ARTICLE:




Load new captcha.
 

TOP WATER AND SOFT DRINKS COMPANIES (2016)
Scoring Methodology by ERNST&YOUNG


 
#
COMPANY NAME
MCR TOTAL SCORING
 
1 COCA-COLA HBC ROMANIA SRL 4,0000
2 QUADRANT - AMROQ BEVERAGES SRL 3,0000
3 ROMAQUA GROUP SA 3,0000
4 MASPEX ROMANIA SRL 3,0000
5 EUROPEAN DRINKS SA 2,0000
6 VALVIS HOLDING DISTRIBUTION SA 2,0000
7 RIO BUCOVINA SRL 2,0000
8 LA FANTANA SRL 2,0000
9 PERLA HARGHITEI SA 2,0000
10 COCA-COLA ROMANIA SRL 2,0000